May 15 Financial Quick Takes: Perceptive leads $60M round for ArcherDx; plus Applied Therapeutics’ IPO, IsoPlexis, Symphogen
ArcherDx completes $60M series B
New investor Perceptive Advisors led a $60 million series B round for ArcherDx Inc. (Boulder, Colo.) that the company plans to use to scale operations, advance its companion diagnostic program and expand its liquid biopsy-based minimal residual disease platform. Existing investors PBM Capital, Boulder Ventures, Longwood Fund and Peierls Foundation also participated.
Applied Therapeutics prices $40M IPO
Applied Therapeutics Inc. (NASDAQ:APLT) regained some ground Wednesday after pricing its IPO below range and slipping in its first day of trading on Tuesday. Applied raised $40 million through the sale of 4 million shares at $10 in its IPO, which valued the diabetic cardiomyopathy and metabolic company at $170.5 million. Applied, which had set a proposed range of $14-$16, closed at $9.75 Wednesday, up $0.35...